SFS
CLDX icon

Sowell Financial Services’s Celldex Therapeutics CLDX Stock Holding History

Sowell Financial Services’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13
Closed – – 911
2021
Q1 		$0 Hold
13
– – ﹤0.01% 3126
2020
Q4 		$0 Sell
13
-200
-94% -$3.6K ﹤0.01% 2709
2020
Q3 		$3K Buy
213
+200
+1,538% +$2.34K ﹤0.01% 2109
2020
Q2 		$0 Hold
13
– – ﹤0.01% 2484
2020
Q1 		$0 Hold
13
– – ﹤0.01% 2451
2019
Q4 		$0 Hold
13
– – ﹤0.01% 2521
2019
Q3 		$0 Buy
+13
New +$30 ﹤0.01% 2395

Other funds holding CLDX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $141M AUM 783.79% 1-Year Est. Return